These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 10844097)

  • 1. Differential modulation of the GYKI 53784-induced inhibition of AMPA currents by various AMPA-positive modulators in cerebellar Purkinje cells.
    Kapus G; Bódi I; Pataki A; Gueritaud J; Székely JI; Tarnawa I
    Eur J Pharmacol; 2000 May; 397(1):43-7. PubMed ID: 10844097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. (S)-2,3-dihydro-[3,4]cyclopentano-1,2,4-benzothiadiazine-1,1-dioxide: (S18986-1) a positive modulator of AMPA receptors enhances (S)-AMPA-mediated [3H]noradrenaline release from rat hippocampal and frontal cortex slices.
    Lockhart B; Iop F; Closier M; Lestage P
    Eur J Pharmacol; 2000 Aug; 401(2):145-53. PubMed ID: 10924919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions among GYKI-52466, cyclothiazide, and aniracetam at recombinant AMPA and kainate receptors.
    Johansen TH; Chaudhary A; Verdoorn TA
    Mol Pharmacol; 1995 Nov; 48(5):946-55. PubMed ID: 7476926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aniracetam, 1-BCP and cyclothiazide differentially modulate the function of NMDA and AMPA receptors mediating enhancement of noradrenaline release in rat hippocampal slices.
    Pittaluga A; Bonfanti A; Arvigo D; Raiteri M
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Apr; 359(4):272-9. PubMed ID: 10344525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allosteric regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionate receptors by thiocyanate and cyclothiazide at a common modulatory site distinct from that of 2,3-benzodiazepines.
    Donevan SD; Rogawski MA
    Neuroscience; 1998 Dec; 87(3):615-29. PubMed ID: 9758228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of 2,3-benzodiazepines at native rat and recombinant human glutamate receptors in vitro: stereospecificity and selectivity profiles.
    Bleakman D; Ballyk BA; Schoepp DD; Palmer AJ; Bath CP; Sharpe EF; Woolley ML; Bufton HR; Kamboj RK; Tarnawa I; Lodge D
    Neuropharmacology; 1996; 35(12):1689-702. PubMed ID: 9076748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions of 2,3-benzodiazepines and cyclothiazide at AMPA receptors: patch clamp recordings in cultured neurones and area CA1 in hippocampal slices.
    Rammes G; Swandulla D; Collingridge GL; Hartmann S; Parsons CG
    Br J Pharmacol; 1996 Mar; 117(6):1209-21. PubMed ID: 8882618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of AMPA receptor modulators on hippocampal and cortical function.
    Black MD; Wotanis J; Schilp DE; Hanak SE; Sorensen SM; Wettstein JG
    Eur J Pharmacol; 2000 Apr; 394(1):85-90. PubMed ID: 10771038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ampakine CX546 bolsters energetic response of astrocytes: a novel target for cognitive-enhancing drugs acting as alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor modulators.
    Pellerin L; Magistretti PJ
    J Neurochem; 2005 Feb; 92(3):668-77. PubMed ID: 15659236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Negative allosteric modulation of AMPA-preferring receptors by the selective isomer GYKI 53784 (LY303070), a specific non-competitive AMPA antagonist.
    Ruel J; Guitton MJ; Puell JL
    CNS Drug Rev; 2002; 8(3):235-54. PubMed ID: 12353057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Negative allosteric modulators of AMPA-preferring receptors inhibit [(3)H]GABA release in rat striatum.
    Harsing LG; Csillik-Perczel V; Ling I; Sólyom S
    Neurochem Int; 2000 Jul; 37(1):33-45. PubMed ID: 10781843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allosteric interactions between cyclothiazide and AMPA/kainate receptor antagonists.
    Yamada KA; Turetsky DM
    Br J Pharmacol; 1996 Apr; 117(8):1663-72. PubMed ID: 8732274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions of GYKI 52466 and NBQX with cyclothiazide at AMPA receptors: experiments with outside-out patches and EPSCs in hippocampal neurones.
    Rammes G; Swandulla D; Spielmanns P; Parsons CG
    Neuropharmacology; 1998; 37(10-11):1299-320. PubMed ID: 9849667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positive modulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptors in prefrontal cortical pyramidal neurons by a novel allosteric potentiator.
    Baumbarger PJ; Muhlhauser M; Zhai J; Yang CR; Nisenbaum ES
    J Pharmacol Exp Ther; 2001 Jul; 298(1):86-102. PubMed ID: 11408529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1-BCP, a memory-enhancing agent, selectively potentiates AMPA-induced [3H]norepinephrine release in rat hippocampal slices.
    Desai MA; Valli MJ; Monn JA; Schoepp DD
    Neuropharmacology; 1995 Feb; 34(2):141-7. PubMed ID: 7542369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kainate receptor-mediated activation of the AP-1 transcription factor complex in cultured rat cerebellar granule cells.
    Kovács AD; Cebers G; Liljequist S
    Brain Res Bull; 2000 May; 52(2):127-33. PubMed ID: 10808083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GYKI 53665, a 2,3-benzodiazepine, non-competitively protects cultured neurones against AMPA toxicity.
    Kovács AD; Szabó G
    Eur J Pharmacol; 1997 Jul; 331(1):93-6. PubMed ID: 9274935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Negative allosteric modulation of wild-type and mutant AMPA receptors by GYKI 53655.
    Partin KM; Mayer ML
    Mol Pharmacol; 1996 Jan; 49(1):142-8. PubMed ID: 8569699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AMPA receptor desensitization predicts the selective vulnerability of cerebellar Purkinje cells to excitotoxicity.
    Brorson JR; Manzolillo PA; Gibbons SJ; Miller RJ
    J Neurosci; 1995 Jun; 15(6):4515-24. PubMed ID: 7540678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential antagonism of alpha-amino-3-hydroxy-5-methyl-4- isoxazolepropionic acid-preferring and kainate-preferring receptors by 2,3-benzodiazepines.
    Wilding TJ; Huettner JE
    Mol Pharmacol; 1995 Mar; 47(3):582-7. PubMed ID: 7700255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.